Edition:
India

Aclaris Therapeutics Inc (ACRS.OQ)

ACRS.OQ on NASDAQ Stock Exchange Global Select Market

8.68USD
15 Nov 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$8.68
Open
$9.08
Day's High
$9.35
Day's Low
$8.64
Volume
166,690
Avg. Vol
107,257
52-wk High
$26.25
52-wk Low
$8.64

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 1.63 -1.057
Jun '18 3.68 -1.009
Mar '18 1.12 -0.979
FY 2017 Dec '17 1.00 -0.802
Sep '17 0.68 -0.631
Jun '17 0.00 -0.558
Mar '17 0.00 -0.482
FY 2016 Dec '16 0.00 -0.491
Sep '16 0.00 -0.499
Jun '16 0.00 -0.623
Mar '16 0.00 -0.646
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 4 3.86 5.30 2.23 12.33
Quarter Ending Mar-19 1 8.20 8.20 8.20 --
Year Ending Dec-18 4 10.27 11.60 8.66 28.53
Year Ending Dec-19 5 48.96 57.40 29.70 120.43
Earnings (per share)
Quarter Ending Dec-18 4 -0.92 -0.75 -1.04 -1.46
Year Ending Dec-18 3 -4.00 -3.94 -4.08 -3.83
Year Ending Dec-19 3 -3.54 -2.57 -4.67 -1.87
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -95.66 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Aclaris Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 0.58 -2.89 99 --
13 Week -1.71 -6.50 99 --
26 Week -14.92 -21.38 99 --
52 Week 12.14 -4.95 99 --
YTD 1.73 -10.66 99 --
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 82.19%
# of Holders: 134
Total Shares Held: 33,643,568
3 Mo. Net Change: 1,821,093
# New Positions: 6
# Closed Positions: 18
# Increased Positions: 54
# Reduced Positions: 53
# Net Buyers: 1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.